Alpha-Stim® products use Cranial Electrotherapy Stimulation (CES) and Microcurrent Electrical Therapy (MET) to manage nervous tension, restlessness, stress, sleeplessness and niggling pain. They use Cranial Electrotherapy Stimulation (CES) to help manage the symptoms of restlessness, agitation, sleeplessness, lack of concentration and mild pain. These devices also use Microcurrent Electrical Therapy to manage mild pain. The devices bring about a feeling relaxation, and calmness similar to the feelings you get after a massage or meditation but without the hassle of taking time out to go do these things. It is very easy to use in your own home or at work or even in a coffee shop. Anytime you can take 20 minutes to relax with Alpha Stim. A very easy to use stress relief product.
Pacific Medistim stocks the Alpha-Stim-100, the Alpha-Stim-SCS (Relaxation Control System) and the Alpha-Stim-PPM (Personal mild Pain Manager). We also stock all product accessories as well as educational DVD's and books.
Pacific Medistim Distributors provides excellent after sales service and is here to answer all of your questions about the use of our devices. However, we can not provide medical advice and we suggest that you contact a health care professional for medical advice.
All Alpha-Stim® products are listed for use in Australia by the Therapeutic Goods Administration (TGA), in New Zealand by Medsafe, and are available for use without a prescription in both these countries. They are also widely used in the USA, where they have been approved by the American Food and Drug Administration (FDA).
The purchase of the Alpha-Stim® devices is covered by some private health funds in Australia.
All Alpha-Stim® devices come with a 5 year Warranty and are used by psychiatrists, psychologists and GP's worldwide.
TO PURCHASE: Click on the online store tab to go directly to our shopping site.
Health care practitioners please contact us for further information.
Company Research Policy
Pacific Medistim Distributors Pty. Ltd. and our parent company Electromedical Products International Inc., make every attempt to encourage research with Alpha-Stim® technology. While we do not fund research, we have developed several important ways in which we can support research in which our devices are used. They are as follows:
• We can assist researchers by making available to them a bibliography of past and ongoing studies, both published and unpublished. This can comprise the review of the literature prior to a study, and will provide researchers with knowledge of prior subjects studied and how they fared.
• We are in daily contact with clinicians around the world and can share research ideas that might answer the most frequently asked clinical questions that have not been researched, and the most interesting clinical observations that might be proven through research.
• We are knowledgeable regarding the needs and requirements of Alpha-Stim® studies. We can assist in preparing your study design, especially the materials and methods section.
• We can arrange to have a statistician complete your study’s statistical analysis for you at our cost, if you wish.
• Upon receipt of an approved protocol we can lend you a reasonable number of Alpha-Stim® devices set up as necessary including double-blinded (with the key provided in a sealed envelope) at no cost to you. We will also provide all the accessories, even batteries, you require to complete your study.
Alpha-Stim® therapy is dosage-dependent, so the higher the current the quicker the treatment. For double-blinding, we set up the devices at only 100 µA which has proven subsensory in many studies completed to date. To compensate for the low current, the time must be increased to one full hour. Half the devices will be modified so as not to conduct any current at all. Since the active treatments are subsensory, this method allows for double-blinding as good as a pharma study using a placebo pill. Research has also shown that there is no reliable “washout” period. In some cases, continued improvement is seen as much as two years after a series of treatments. Accordingly, only one way crossovers are possible, from the sham treated group to an active treatment. This can be done maintaining the original subsensory criteria of 100 µA which would increase the N and allow for half the subjects to serve as their own controls. Alternatively, this optional second arm can use the original sham group in an open clinical trial where the current is raised to a comfortable level in the same way as it would be done in actual practice. This usually achieves better results while still allowing for the original sham subjects to serve as their own controls. We need a few weeks notice to build sham devices. Then we can either mark half with a dot and note which are which in the sealed study key, or we will simply mix them up and the only differentiation would be by serial number if the study allows for randomization by simply picking a device out of a box.
We are very pleased at your interest in possibly using Alpha-Stim® technology in your research. Please do not hesitate to contact me at the telephone number or email address below at the first opportunity that we can be of assistance to you in this process.
Daniel L. Kirsch, PhD, DAAPM, FAIS (Diplomate of the American Association of Pain Management)(Fellow of the American Institute of Stress)
(Electromedical Products International Inc. Texas, USA)
If you reside in Australia or New Zealand, Please contact Roy Scott (Pacific Medistim Distributors Pty.Ltd. Australia & NZ) Ph: 1300 885230 or info@pacificmedistim.com.au
Always use as directed, always read the label. If symptoms persist contact a health care professional. ARTG No. 137247
MEDISTIM DISTRIBUTORS Aust & NZ